MELANOMA STAGE III
Clinical trials for MELANOMA STAGE III explained in plain language.
Never miss a new study
Get alerted when new MELANOMA STAGE III trials appear
Sign up with your email to follow new studies for MELANOMA STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Bone drug boosts immunotherapy in advanced melanoma trial
Disease control CompletedThis study tested whether adding denosumab (a bone-strengthening drug) to standard immunotherapy (pembrolizumab or nivolumab) could help control advanced melanoma that has spread. Twenty-five adults with stage III or IV melanoma that had not been treated with immunotherapy before…
Matched conditions: MELANOMA STAGE III
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 17, 2026 02:16 UTC
-
Experimental combo shows promise for Tough-to-Treat melanoma
Disease control CompletedThis study tested a new cancer vaccine (BNT111) combined with an immunotherapy drug (cemiplimab) in 184 people with advanced melanoma that had stopped responding to prior treatment. The goal was to see if the combination could shrink tumors better than either treatment alone. Par…
Matched conditions: MELANOMA STAGE III
Phase: PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated May 14, 2026 12:06 UTC